HER2aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HER2aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 35, Pages 7926
Publisher
Baishideng Publishing Group Inc.
Online
2016-09-14
DOI
10.3748/wjg.v22.i35.7926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rediscovering Secondary Tumors of the Prostate in the Molecular Era
- (2016) Nicola Fusco et al. ADVANCES IN ANATOMIC PATHOLOGY
- Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design
- (2016) Jason K. Sicklick et al. CANCER AND METASTASIS REVIEWS
- Heterogeneity of liver cancer and personalized therapy
- (2016) Liang Li et al. CANCER LETTERS
- Molecular targeted therapy for the treatment of gastric cancer
- (2016) Wenting Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
- (2016) Susan D Richman et al. JOURNAL OF PATHOLOGY
- A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status
- (2016) Hiroshi Yoshida et al. VIRCHOWS ARCHIV
- Personalized medicine in gastric cancer: Where are we and where are we going?
- (2016) Alexandre A Jácome WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular genetics and targeted therapeutics in biliary tract carcinoma
- (2016) Eric I Marks WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis
- (2016) Xiaoping Li et al. World Journal of Surgical Oncology
- Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
- (2016) Debora de Melo Gagliato et al. Oncotarget
- Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
- (2016) Chiara Arienti et al. Oncotarget
- HER2 expression status in diverse cancers: review of results from 37,992 patients
- (2015) Min Yan et al. CANCER AND METASTASIS REVIEWS
- Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis
- (2015) Sheng-wen Wu et al. Diagnostic Pathology
- Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy
- (2015) Ibrahim H Sahin et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas
- (2015) Caterina Marchiò et al. GYNECOLOGIC ONCOLOGY
- Biliary Tract Cancers: Understudied and Poorly Understood
- (2015) Emily Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2/neu-directed therapy for biliary tract cancer
- (2015) Milind Javle et al. Journal of Hematology & Oncology
- Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
- (2015) Andrea Sartore-Bianchi et al. JNCI-Journal of the National Cancer Institute
- Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
- (2015) Emanuele Valtorta et al. MODERN PATHOLOGY
- Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer
- (2015) M. A. Blum Murphy et al. Expert Review of Gastroenterology & Hepatology
- Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
- (2015) Charlotte KY Ng et al. GENOME BIOLOGY
- Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer
- (2015) Andrea Sartore-Bianchi et al. JNCI-Journal of the National Cancer Institute
- Targeted therapy in gastroesophageal cancers: past, present and future: Figure 1.
- (2015) Janghee Woo et al. Gastroenterology Report
- Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer
- (2014) G.-Q. Zhu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma
- (2014) Annette Feuchtinger et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies
- (2014) Sheng-wen Wu et al. TUMOR BIOLOGY
- Comment on Gu et al. entitled “Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis”
- (2014) Jun Li et al. TUMOR BIOLOGY
- Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis
- (2014) Jianchun Gu et al. TUMOR BIOLOGY
- An updated review of gastric cancer in the next-generation sequencing era: Insights from bench to bedside andvice versa
- (2014) Hiroyuki Yamamoto WORLD JOURNAL OF GASTROENTEROLOGY
- Significance of human epidermal growth factor receptor 2 expression in colorectal cancer
- (2014) JINHUA TU et al. Experimental and Therapeutic Medicine
- Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future
- (2014) Hwi Young Kim et al. Liver Cancer
- Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis
- (2013) Cheng Chen et al. ARCHIVES OF MEDICAL RESEARCH
- Lapatinib sensitivities of two novel trastuzumab-resistant HER2 gene-amplified gastric cancer cell lines
- (2013) Yukiko Oshima et al. Gastric Cancer
- Molecular characterization of gallbladder cancer using somatic mutation profiling
- (2013) Milind Javle et al. HUMAN PATHOLOGY
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
- (2013) Nicola Fusco et al. MODERN PATHOLOGY
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Clinical and molecular characterization of HER2 amplified-pancreatic cancer
- (2013) Angela Chou et al. Genome Medicine
- Marked radiographic response of a HER-2-overexpressing biliary cancer to trastuzumab
- (2013) Steven Steven Sorscher Cancer Management and Research
- Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
- (2013) Anna Sapino et al. Frontiers in Oncology
- Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
- (2012) Isabela Martins Gonzaga et al. BMC CANCER
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
- (2012) H. H. Yoon et al. CLINICAL CANCER RESEARCH
- Dramatic Response to Trastuzumab and Paclitaxel in a Patient With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Cholangiocarcinoma
- (2012) Lisa Y. Law JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
- (2012) Anne M. Horgan et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic Review and Meta-analysis of the Influence of HER2 Expression and Amplification in Operable Oesophageal Cancer
- (2012) David S. Y. Chan et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Medical therapies for hepatocellular carcinoma: a critical view of the evidence
- (2012) Augusto Villanueva et al. Nature Reviews Gastroenterology & Hepatology
- Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas
- (2011) Qingguo Li et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
- (2011) R. Ghosh et al. CANCER RESEARCH
- p95HER2 and Breast Cancer
- (2011) J. Arribas et al. CANCER RESEARCH
- Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
- (2011) Aida Laurinaviciene et al. Diagnostic Pathology
- Emerging pathways and future targets for the molecular therapy of pancreatic cancer
- (2011) Vanja Vaccaro et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- HER-2/neu Assessment for Gastric Carcinoma: Validation of Scoring System
- (2011) Ivana Mrklic et al. HEPATO-GASTROENTEROLOGY
- Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections*
- (2011) Stephen Lee et al. HISTOPATHOLOGY
- Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation
- (2011) Rupert Langer et al. MODERN PATHOLOGY
- A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer
- (2011) Young E. Whang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma
- (2010) Bettina G. Papouchado et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
- (2010) Ymera Pignochino et al. BMC CANCER
- Combinatorial biomarker expression in breast cancer
- (2010) Emad A. Rakha et al. BREAST CANCER RESEARCH AND TREATMENT
- Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors
- (2010) Matthew D. Galsky et al. INVESTIGATIONAL NEW DRUGS
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Emerging Technologies for Assessing HER2 Amplification
- (2009) Frédérique Penault-Llorca et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry
- (2009) Yukie Sato-Kuwabara et al. BMC CANCER
- Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
- (2009) Dara O Kavanagh et al. BMC CANCER
- HER2 overexpression correlates with survival after curative resection of pancreatic cancer
- (2009) Masahiro Komoto et al. CANCER SCIENCE
- HER-2 amplification is highly homogenous in gastric cancer
- (2009) Andreas H. Marx et al. HUMAN PATHOLOGY
- EGFR and HER2 expression in advanced biliary tract cancer
- (2009) Jan Harder et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- HER2 testing in the UK: further update to recommendations
- (2008) R A Walker et al. JOURNAL OF CLINICAL PATHOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started